Translational Research Grants

Nephrotic Syndrome Study Network (NEPTUNE) Career Development Fellowship

Deadline for application: November 2, 2010

Objectives: The NEPTUNE Career Development program is designed to support advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease. Successful applicants will design and carry out an individually tailored program that combines a clearly defined training component with a mentored research experience that employs the unique resources of NEPTUNE.

• Eligibility:

o Clinical fellows (MD, MD/PhD, or equivalent degrees) who have completed their clinical training in nephrology or pathology or a subspecialty relevant to the study of glomerular disease in humans
o Advanced PhD post-doctoral fellows with training in biostatistics or translational research who seek advanced training in clinical research in human glomerular disease
o Junior faculty with training similar to that noted above who are interested in establishing a career investigating glomerular disease in humans
o Established investigators interested in refocusing their investigative path to include studies of glomerular disease in humans
o Individuals must be specifically interested in training to do translational or clinical research. Translational research can be broadly interpreted to include laboratory or in silico investigations that can be directly applied to studying human glomerular disease. Examples of these types of investigations include but are not limited to identification of molecular biomarkers, studies involving techniques of human genetics, or studies involving generation or application of the tools of biostatistical modeling and epidemiological studies.
o Applicants can come from Consortium participant institutions or elsewhere as long as trainee relocates to or is located in close physical proximity to a participant institution for training.

This training program is NOT intended for pre-doctoral candidates or junior level post-doctoral fellows.

• Training Program should have two components:

o Mentored research project with an established investigator conducting clinical or translational research in the area of or related to human glomerular disease; ideally, the trainee’s project should employ the unique infrastructure, clinical data, or specimens assembled by NEPTUNE

o Applicants are encouraged to create an individualized training program that would enhance their formal skills in clinical research design, statistics, etc. relevant to their intended investigative path. If appropriate, this might include formal class work, participation in ongoing seminar series, or other appropriate training. Consideration should be given to employing local resources to help defray the costs of this training.

• Requirements

o Applicants must devote a minimum of 50% effort to their training
o Applicant institutions must provide written commitment to protecting trainee’s time and providing financial support of the applicant

• Funding

o A maximum of $60,000 per year to support salary and fringe benefits only
o Duration of grant support will be a minimum of 1 and maximum of 2 years
o In necessary, applicant institutions are encouraged to contribute to financial and other resources necessary for the success of the proposed training program; the use of CTSA funding and other institutional resources should be considered
o Indirect Costs: no institutional overhead will be funded since this fellowship will be funded by Nephcure

The NephCure Foundation 15 Waterloo Ave Berwyn, PA 19312

1.866 NephCure (637-4287)

info@nephcure.org

National Psoriasis Foundation Translational Research Grant

The National Psoriasis Foundation is seeking grant applications that focus on the rapid translation of scientific discoveries arising from laboratory, clinical or population-based studies into clinical applications that have a clear benefit for patients with psoriasis and/or psoriatic arthritis.

Research pathways:
Priority consideration will be given to applications that address one or more of the Foundation's research pathways: (1) genetics, (2) cell biology, (3) immunology, and (4) epidemiological/health services research.

Anticipated number of awards:
It is anticipated that as many as four new Translational Research Grants will be awarded in 2011. Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications.

Budget and Project period:
Applicants may request up to $100,000 (direct costs only) per year. The total project period for the application submitted in response to this RFP is two (2) years.

Research plan length:
The research proposal must not exceed eight (8) pages, including figures and tables, excluding references.

Eligibility:
It is expected that the principal investigator will be personally and actively responsible for the conduct of the research and is considered eligible by his or her institution to apply for a research grant. The principal investigator need not be a United States citizen.

Important deadlines:
The applications must be received by Monday October 4, 2010. The applications will be evaluated by an expert panel of peer reviewers and awards will be made no later than March 1, 2011.

Application:
Completed applications should be converted to a single PDF file and submitted by e-mail to: research@psoriasis.org.

Questions:
For more information on the Translational Research grant program please contact the Director of Research, Bruce F. Bebo, Jr., PhD. Phone: 503-546-8404; E-mail: research@psoriasis.org.

Request For Proposals: Targeted Biomedical Research Exploring the Mechanisms for HIV Persistence and the Potential for HIV Eradication

Deadline: September 16, 2010

Available Support

amfAR, The Foundation for AIDS Research, is pleased to announce the availability of targeted support for biomedical research projects relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication.

Funding will be available for:

Research Grants—$100,000 for direct costs plus up to 20 percent for indirect costs. The performance period for grants awarded under this RFP will be for one year starting March 1, 2011.

Fellowships—Each fellowship is funded for a total of up to $125,000: A maximum of $110,000 is allowed for project-specific direct costs ($45,000 per year for salary and fringe benefits and $20,000 over two years for laboratory supplies). It is expected that fellows will devote a minimum of 85 percent time and effort to the approved fellowship project. An additional $3,636 is provided to support attendance at amfAR-designated consultations for a direct cost maximum of $113,636. Institutional indirect costs may not exceed 10 percent of direct costs. The performance period for fellowships awarded under this RFP will be for two years starting March 1, 2011.

amfAR's research program is driven by the Foundation's mission to end the global AIDS epidemic through innovative research. amfAR plays a uniquely important role in AIDS research, identifying critical gaps in our knowledge of HIV and AIDS, and supporting groundbreaking studies that often lack the preliminary data required by more traditional funders. The Foundation's research program focuses on efforts to prevent HIV infection among vulnerable populations and to improve treatment, with the ultimate goal of eradicating the virus in people living with HIV infection.

This RFP solicits proposals relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication. Highly active antiretroviral therapy (HAART) has significantly impacted the health of individuals infected with HIV-1. However, if therapy is interrupted, there is a rapid resumption of viral replication. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication. amfAR wishes to support basic, clinical, and especially translational research exploring the mechanisms whereby HIV infection persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately eliminating HIV infection.

Specific areas of interest include:

* Novel strategies/approaches for preventing the establishment of, or eliminating, latent HIV virus. Use of known activators will not be considered responsive to the RFP.
* Understanding and characterizing cellular and tissue locations of reservoirs and their relative importance in maintaining infection in face of ART and immune system activity
* Understanding the extent to which persistence is due to true latency versus low level replication. How does effect of ART differ in each case? If true latency, does this mean ART intensification will ultimately not lead to eradication? If low level replication, does this mean ART could ultimately eradicate the virus?
* Is there a threshold viral load below which infection will not be re-seeded?
* Studies in elite controllers and/or acute infection cohorts that may help define new mechanisms of persistence that are not HLA-driven
* Does persistent immune activation point to a need for long-term immune reconstitution strategies? Are there benefits to immune suppressive therapy?
* Improved assays to quantify integrated versus unintegrated DNA. Do these differ between tissues, in treated versus untreated patients, or in progressors versus controllers?
* Improved assays to more efficiently and inexpensively measure extremely low viral load (e.g., to 0.01 copies/ml)
* Deep sequencing approaches to compare viruses in different tissue compartments with those in plasma following treatment interruption, with a view to identifying sources of viral rebound
* What are the consequences of chronic immune activation, in the presence or absence of ART, on tissues such as the gut, and can the damage be reversed if immune activation is controlled?

Types of Funding and Qualifications:

Research Grants—Principal investigators for research grants must be faculty-level researchers affiliated with a nonprofit institution. Research grants are given to nonprofit institutions worldwide to support investigator-led projects approved by the Foundation. In general, funds are applied to direct costs of salaries and fringe benefits for professional and technical personnel, laboratory supplies and equipment, travel, and the publication of findings. Research grants are awarded for one year without assurance of continued funding.

Fellowships—An amfAR fellowship is a grant that encourages the postdoctoral (M.D., Ph.D., or equivalent) investigator with limited experience in the field to advance a career in HIV/AIDS research. Fellowship grants are applied to direct costs incurred in the course of an amfAR-approved research project. Allowed costs are limited to laboratory supplies, the fellow’s salary and fringe benefits, and costs incurred by participation in amfAR-designated consultations. Fellowships are awarded for two years and may not be renewed for additional funding. amfAR fellows and mentors must be affiliated with the same nonprofit institution. The applicant’s interest in a career in HIV/AIDS will be demonstrated by previous relevant work at the postdoctoral fellow or instructor level and will be carefully evaluated. The fellowship applicant must be mentored by an experienced investigator who: (a) is qualified to oversee the proposed research; (b) has successfully supervised postdoctoral fellows; and (c) is at the associate professor level or higher.

Submission Requirements and Deadlines

Letter of intent (LOI) forms and instructions may be obtained by sending an email to grants@amfar.org.

Please include the following in the body of the e-mail:

* applicant’s name
* mentor’s name (fellowship grants only)
* institution
* proposed project title

amfAR Grants
120 Wall Street, 13th Floor
New York, NY 10005-3908, USA

An e-mailed (electronic) copy and signed hard copy of the LOI are required of all applicants.

Submission of an LOI is not a guarantee of eligibility to submit a full application. The pre-application process is highly competitive. Only a limited number of investigators submitting an LOI will be invited to submit a full application.

Pediatric Radiology Pilot Award

In response to surveys of the membership, surveys of past grant recipients and SPR Board discussions, in February 2010, the SPR Research and Education Foundation established the Pediatric Radiology Pilot award.

This new grant award is designed to provide a higher level of support for pediatric radiology-related projects of merit.

* This grant can be used to fund protected time.
* Amount – up to $50,000.
* Funding will be based on merit, including expertise and available resources, but should also endeavor to focus on unique aspects of imaging or image-guided therapy/intervention in children, promote the importance of imaging or imaging expertise in improving health care in children, embrace broader cross boundary impact, including public policy or translational medicine, cultivate multidisciplinary cooperation, and provide opportunities for additional funding

The annual grant deadline is March 15.

Society for Pediatric Radiology
1891 Preston White Drive
Reston, VA 20191

703-648-0680
SPR@acr.org

Foundation for Anesthesia Education and Research Grants Program

FAER offers four types of grants.

Next Grant Deadline: February 15, 2011

Mentored Research Training Grant - Basic Science (MRTG-BS)

The Mentored Research Training Grant - Basic Science (MRTG-BS) is a two-year grant (the first year is funded at $75,000 and the second year is funded at $100,000) awarded for basic science research. Individuals who have completed their clinical anesthesia training and have academic appointments at the instructor or assistant professor level, no more than 10 years after completion of residency or fellowship, are eligible to apply. The recipient must be guaranteed 75% protected non-clinical time for research, which may include research related to but not specifically for the project being funded. The research mentor must have a minimum of 40% non-clinical academic time devoted to research activities during the two-year duration of the grant. A detailed mentoring and career development plan is part of the application for an MRTG-BS.

Mentored Research Training Grant - Clinical and Translational Science (MRTG-CT)

The Mentored Research Training Grant - Clinical and Translational Science (MRTG-CT) is a two-year grant (the first year is funded at $75,000 and the second year is funded at $100,000) awarded for clinical or translational research. Individuals who have completed their clinical anesthesia training and have academic appointments at the instructor or assistant professor level, no more than 10 years after completion of residency or fellowship, are eligible to apply. The recipient must be guaranteed 75% protected non-clinical time for research, which may include research related to but not specifically for the project being funded. The research mentor must have a minimum of 40% non-clinical academic time devoted to research activities during the two-year duration of the grant. A detailed mentoring and career development plan is part of the application for an MRTG-CT.
Research Fellowship Grant (RFG)

A Research Fellowship Grant (RFG) provides a one-year $75,000 grant to individuals participating in a clinical training program that is part of an ACGME-approved anesthesiology residency program. This 12 contiguous months of FAER-sponsored research must be combined with at least six months of research that is part of the residency program continuum (CBY – CA3 years), consistent with the ABA templates for research, for a total of 18 months of research experience. Alternately, the 12 months of FAER-sponsored research can be in conjunction (either before or after) a one-year clinical fellowship sponsored by an ACGME-approved residency program. A research mentor must be identified and must provide written commitment to strong, direct involvement in all research activity. During the 12-month fellowship period the recipient will be required to spend a minimum of 80% of his or her time in research related to but not specifically on the project.

Research Education Grant (REG)

A Research in Education Grant (REG) is a two-year grant to be awarded competitively to individuals who have completed their clinical anesthesia training and have academic faculty appointments. The REG is intended to stimulate career development for anesthesiologists interested in research into the concepts, methods and techniques of education in anesthesiology in all its forms, including novel approaches to educating medical students, residents, fellows and practicing physicians. Applications from both junior and senior faculty are accepted. A mentor with expertise in education is required for all applicants. Each of the two years is funded at $50,000 per year. The recipient must be guaranteed a minimum of 40% protected non-clinical time for research related to this education project. Application may be made for a second two-year award and will be reviewed competitively with other applications.

Foundation for Anesthesia Education and Research
200 First Street SW, WF6-674
Rochester, MN 55905
Phone: (507) 266-6866
Fax: (507) 284-0291

Maxwell A. Pollack Award for Productive Aging

The Maxwell A. Pollack Award for Productive Aging recognizes instances of practice informed by research and analysis, research that directly improved policy or practice, and distinction in bridging the worlds of research and practice. Individual(s) who are mid-career and actively engaged in the conception and development of innovative programs that demonstrate excellence in translating research into practical application or policy are eligible for this award. The individual(s) should be visionary in their approach to meeting current and critical needs of an older population in new and creative ways.

The award is presented at the GSA Annual Scientific Meeting. The awardee will also be expected to give a presentation about the program for which the award was received. The award includes cash, certificate and a symbolic emblem totaling $8,500. Travel expenses to defray airfare and one day per diem will be reimbursed for the awardee not to exceed $750 per person. Airfare will be calculated at the supersaver economy rate and hotel at the GSA convention rate. This award is funded by the New York Community Trust through a generous gift from Maxwell A. Pollack Fund.

Deadline: First Monday in May.

Requirements

Must be nominated by, or the nomination must be supported by a member of GSA.
Formal Nomination Letter
Detailed description of the specific example(s) of bridging practice and research including...
The policy or practice change that occurred and why the contribution is significant.
The research upon which the policy or practice change is based.
The significant contributions of the research to this policy and/or practice.
The potential impact of this change on the lives of older people.
The broader impact or potential for replication.
A current Curriculum Vitae.
At least 2 (two) letters of endorsement.

In order to nominate someone for the Maxwell A. Pollack Award, please send your nomination packet to awards@geron.org with a subject of "Pollack Award Nomination - NOMINEE NAME HERE." Please remember to substitute your nominee's name in the subject.

Gerontological Society of America
1220 L Street NW, Suite 901
Washington, DC 20005

OFFICE: 202.842.1275
FAX: 202.842.1150

Advanced Transplant Provider Award

Deadline: September 14, 2010

Attendence to ASTS Winter Symposium:
Complimentary Registration
2 nights hotel accomodations
Travel expenses (up to $750)

Description This award recognizes the time and effort dedicated to advancing clinical practice through translation of scientific information, development of standards and clinical mentoring of the Advanced Transplant Provider, with a travel prize to the ASTS State of the Art Winter Symposium. Self nominations are accepted.

Amount Expenses (registration, 2 nights hotel accomodations, and travel costs up to $750) associated with attendance at the ASTS State of the Art Winter Symposium

Applicant Eligibility

Please review these eligibility requirements to ensure that you apply for the appropriate award.

ASTS Member (Associate Members only)
May not have won the ASTS Advanced Transplant Provider award within the last five years

Submission Requirements Online Application Form
Nominator must write a maximum 500 word description of the advanced transplant provider’s contributions to the field of transplantation
CV

Other Requirements The Awardee must attend the ASTS Awards Ceremony at ASTS State of the Art Winter Symposium to formally accept the award.

Review
Criteria Applications will be scored on the following criteria:

Consistently promotes evidence based patient driven excellence
Serves as a role model in skilled communication, multidisciplinary collaboration and effective decision making in the various phases of transplantation.
Enriches the field of transplantation by demonstrating leadership as a mentor in achieving excellence.
Demonstrates academic contributions to the field of transplantation thru publication, public speaking or society committee involvement.
Furthers the ASTS mission thru project initiates that benefit patients, promotes education and advances the science of transplantation.

Other 1 award available annually

* The funding of ASTS research awards is contingent upon the availability of funds and the receipt of qualified applications.

American Society of Transplant Surgeons 2461 South Clark St., Suite 640 Arlington, VA 22202 Phone: 703-414-7870 Fax: 703-414-7874

Caring for Carcinoid Foundation-American Association for Cancer Research Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research

Application Deadline: September 15, 2010, at 12:00 noon Eastern Time

Decision Date: January 15, 2011

Start of Grant Term: February 1, 2011

Recognition Event for Grant Recipients at AACR 102nd Annual Meeting 2011: April 5, 2011

The Caring for Carcinoid Foundation-AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research represent a joint effort to promote and support innovative cancer research. These grants are available to independent junior and senior investigators to develop and study new ideas and approaches that have direct application and relevance to carcinoid tumors or pancreatic neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, clinical, or epidemiological cancer research.

Applications are invited from researchers currently in the field as well as from investigators with experience in other areas of cancer research who have promising ideas or research approaches that can be applied to carcinoid tumor and pancreatic neuroendocrine tumor research.

These two-year grants will provide $250,000 over the grant term ($125,000 per year). Grant funds support direct research expenses, which may include the salary and benefits of the grant recipient and any collaborators (limited to 25 percent of the total grant), postdoctoral or clinical research fellows and/or research assistants, equipment, travel and supplies (indirect costs not permitted).

Mentored researchers working in carcinoid tumor and pancreatic neuroendocrine tumor research should consider applying for the Raymond and Beverly Sackler AACR Fellowships for Ileal Carcinoid Tumor Research.

It is anticipated that two grants will be funded.

Research Project Criteria

Proposals will be accepted for new ideas and innovative approaches that have direct application and relevance to carcinoid tumors and pancreatic neuroendocrine tumors. Proposed research projects can be any in discipline including basic, translational, clinical, or epidemiological cancer research.

Applications are invited from researchers currently in the field as well as from investigators with experience in other areas of cancer research who have promising ideas or research approaches that they will directly apply to carcinoid tumors or pancreatic neuroendocrine tumors. Investigators who have powerful experimental tools that will lead to a better understanding of neuroendocrine tumor biology, elucidate the mechanisms of currently available therapies in neuroendocrine tumors, and identify new treatment targets for carcinoid tumors or pancreatic neuroendocrine tumors are encouraged to apply. The applicability of the proposed project to carcinoid tumor or pancreatic neuroendocrine tumor research must be fully described. A track record of research in this specific field is not a requirement for funding.

Genomic, RNA, and proteomic studies of carcinoid tumors and pancreatic neuroendocrine tumors that may complement ongoing genome-wide sequencing efforts funded by Caring for Carcinoid Foundation will be considered but special emphasis will be placed on research that is not duplicative of projects currently funded by the Caring for Carcinoid Foundation (see www.caringforcarcinoid.org for listing of grants).
Applicant Eligibility Criteria

Applicants must have a doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree, or a combined clinical and research doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical or research institution anywhere in the world. There are no citizenship or geographic requirements.

Employees or subcontractors of a government entity or for-profit private industry are not eligible. Exceptions may apply if an applicant holds a full-time position at a veterans' hospital or national laboratory in the United States. Employees or subcontractors of a government entity or for-profit private industry may serve as collaborators, but no grant funds may be directed towards these individuals or their respective institutions. Contact the AACR before submitting an application to determine your eligibility.

Applicants with a question about eligibility are encouraged to contact the AACR at grants@aacr.org, prior to submitting an application.

Program Guidelines & Application Instructions

Letters of Intent are now being accepted via the proposalCENTRAL website. Please download the Program Guidelines and Application Instructions document for more information.

Generously Supported By
Caring for Carcinoid Foundation

Inquiries
Ms. Julia Laurence, Program Associate
Telephone: (267) 646-0655
Fax: (215) 440-9372
Email: julia.laurence@aacr.org

Raymond and Beverly Sackler American Association for Cancer Research Fellowships for Ileal Carcinoid Tumor Research

Two-year grant of $100,000. Two grants will be awarded this cycle. The Fellowships are open to postdoctoral and clinical research fellows. Applications are invited from researchers currently in the field as well as from investigators with experience in other areas of cancer research who have promising ideas or research approaches that can be applied to ileal carcinoid tumor research. Proposed research may be basic, translational, clinical, or epidemiological in nature and must have direct application and relevance to ileal carcinoid tumors.

Applicants must have a doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D.,
D.N.S., Pharm.D., or equivalent doctoral degree, or a combined clinical and research doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

Applicants must be in the first 5 years of a postdoctoral or clinical research fellowship at an academic, medical, or research institution anywhere in the world at the start of the grant term on February 1, 2011. Applicants must have started their fellowship no earlier than February 2, 2006 and no later than February 1, 2011. There are no citizenship or geographic requirements.

Application Deadline: September 15, 2010, at 12:00 noon, Eastern Time

Inquiries
Hanna Hopfinger, Grants Program Assistant
Telephone: (267) 646-0665
Fax: (215) 440-9372
E-mail: grants@aacr.org

American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors/BrainLAB International Research Fellowship

The AANS/CNS Section on Tumors is pleased to announce the establishment of a new international research fellowship program called Section on Tumors /BrainLAB International Research Fellowship.

This name recognizes the partnering of the Tumor Section with BrainLAB AG, who has generously provided the funding for this new fellowship program.

Purpose of Fellowship: To provide a program for neurosurgeons from outside the United States or Canada to perform clinical, translational or basic research in the field of neurosurgical oncology in a clinical and/or laboratory setting within the United States.

Eligibility: The fellowship is open to foreign neurosurgeons or graduating residents from outside the United States or Canada.

Stipend: $50,000 salary support & travel expenses for a period of one year

Important Dates:

* Annual application submission is November 17th
* The fellowship will be awarded on January 15th
* Commencement of the fellowship is July 1 of each year.

Application: The application includes a formal proposal (not to exceed 5 pages) that outlines the aims of the project, the background/rationale for the work, any preliminary results or supporting data for the project, and a detailed study design. The applicant must also submit a personal biographical sketch, a description of future academic plans, and a statement of why studying in the U.S.A. will be important for the completion of the work.

The Sponsoring Investigator of the accepting laboratory/program will be required to submit a letter in support of the applicant, verifying the investigator’s willingness to mentor the applicant and provide necessary space and supplies for the applicant during the project/study period. Two letters of recommendation are also required. Sponsor must be a member of the AANS/CNS Tumor Section.

Host institutions: The Tumor Section has established a list of investigators in the U.S.A. who are interested in sponsoring a foreign neurosurgeon:

Cedars Sinai Medical Center
Cleveland Clinic/Brain Tumor Institute-Center for Translational Therapeutics
Johns Hopkins
MD Anderson Cancer Center
Mount Sinai School of Medicine
Ohio State University
Penn State University
Stanford University Medical Center
UCLA Medical Center, David Gaffen School of Medicine
UCLA School of Medicine
University of Alabama at Birmingham
University of Chicago
University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Research Foundation
University of Texas M.D. Anderson Cancer Center
University of Toronto

Review Process: Fellows will be chosen through a competitive application process open to all foreign neurosurgeons or graduating residents from outside the United States or Canada. A review committee, consisting of the chairman of the AANS/CNS Tumor Section and five others appointed by the chairman, will examine all submissions. Applications will be judged based on the novelty and scientific merit of the proposed study, the credentials of the applicant, and the support provided by the accepting program/laboratory.

Investigative Categories: Although the focus must be on neurosurgical oncology, all categories of investigative studies will be considered eligible for this fellowship, including (but not limited to) basic science, epidemiology, anatomic studies, preclinical or translational studies, and clinical trials. Areas of study may be within any subspecialty of neurosurgical oncology, including (but not limited to) primary brain tumors, metastatic brain tumors, spine and spinal cord tumors, peripheral nerve tumors, and skull base tumors. Preference will be given to proposals undertaking hypothesis-driven research.

Awarded Fellows: The winning fellow will be required to submit a written Mid-Year Progress Report and, at the completion of the project, a written Summary Report describing the results of the study. The applicant may also present an oral summary of the project at the AANS or CNS Annual Meeting upon completion of the fellowship.

It is hoped that this fellowship will become a source of education and collaboration between centers in the US and foreign countries. The Section on Tumors thanks all those who have worked so hard to make this fellowship possible. The Section is particularly grateful to BrainLAB AG who have provide the financial support for this program through an educational grant.

For more information please contact the Development Department of the American Association of Neurological Surgeons (AANS) at 847-378-0500 or jaq@aans.org.